×
Breaking News
TOPICS IN FOCUS SERIES | Guidelines for the Management of Thalassaemia Syndromes
ANNUAL REPORT 2024 | A Year of Resilience and Progress
SICKLE CELL DISEASE | Inflammation during Menstrual Cycle May Trigger Pain Crises
SEVERE APLASTIC ANAEMIA | Stem Cell Transplant Opens New Possibilities
BOOSTING DONOR HEALTH | How Iron Speeds Post-Donation Recovery
SICKLE CELL DISEASE | Limited Progress in Sickle Cell Disease Highlights Barriers to Treatment Access
SICKLE CELL DISEASE | Intranasal Fentanyl Shows Promise for Rapid Pain Relief in Adults
EMPOWERING NURSING PRACTICE IN HAEMOGLOBINOPATHIES | Discover the New TIF Guide
YOUR RIGHTS, YOUR VOICE | The New Edition of TIF’s Essential Patient Guide is Here!
1st TIF PAN AMERICAN CONFERENCE & 2nd RAIN SUMMIT | Poster Abstracts
English
العربية
English
Ελληνικά
Français
Deutsch
Italiano
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
Clinical trial updates
Clinical trial updates
July 27, 2023
PYRUKYND®
Read More »
June 13, 2019
Sickle Cell Disease
Read More »
Previous page
Back to top button
Close
Search for
